FibroGen Inc (FGEN)
0.39
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 11:11
FibroGen Profit Margin (Quarterly): -36.87% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -36.87% |
| June 30, 2024 | -30.69% |
| March 31, 2024 | -58.91% |
| December 31, 2023 | -207.2% |
| September 30, 2023 | -158.5% |
| June 30, 2023 | -197.8% |
| March 31, 2023 | -212.1% |
| December 31, 2022 | -192.6% |
| September 30, 2022 | -582.5% |
| June 30, 2022 | -243.7% |
| March 31, 2022 | -103.9% |
| December 31, 2021 | -810.5% |
| September 30, 2021 | 31.93% |
| June 30, 2021 | -549.9% |
| March 31, 2021 | -186.7% |
| December 31, 2020 | -90.21% |
| September 30, 2020 | 74.95% |
| June 30, 2020 | -198.9% |
| March 31, 2020 | -321.1% |
| December 31, 2019 | -1.23K% |
| September 30, 2019 | -149.0% |
| June 30, 2019 | 60.56% |
| March 31, 2019 | -190.3% |
| Date | Value |
|---|---|
| December 31, 2018 | 19.39% |
| September 30, 2018 | -146.6% |
| June 30, 2018 | -53.29% |
| March 31, 2018 | -129.7% |
| December 31, 2017 | -110.3% |
| September 30, 2017 | -60.32% |
| June 30, 2017 | -105.4% |
| March 31, 2017 | -104.0% |
| December 31, 2016 | -85.55% |
| September 30, 2016 | -80.24% |
| June 30, 2016 | 27.24% |
| March 31, 2016 | -98.44% |
| December 31, 2015 | -210.2% |
| September 30, 2015 | -230.8% |
| June 30, 2015 | 47.33% |
| March 31, 2015 | -284.5% |
| December 31, 2014 | -313.9% |
| September 30, 2014 | -289.4% |
| June 30, 2014 | 52.06% |
| March 31, 2014 | -90.85% |
| December 31, 2013 | -216.1% |
| September 30, 2013 | 55.16% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.23K%
Minimum
Dec 2019
74.95%
Maximum
Sep 2020
-265.3%
Average
-195.2%
Median
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| Arbutus Biopharma Corp | -1.47K% |
| GlycoMimetics Inc | -- |
| Cidara Therapeutics Inc | -- |
| Cue Biopharma Inc | -259.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -33.69% |
| Gross Profit Margin (Quarterly) | 88.57% |
| Operating Margin (Quarterly) | 3.83% |
| Return on Net Operating Assets | -62.90% |